Importance of Murine Study Design for Testing Toxicity of Retroviral Vectors in Support of Phase I Trials
Open Access
- 1 April 2007
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 15 (4) , 782-791
- https://doi.org/10.1038/sj.mt.6300083
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Genotoxicity of Retroviral Integration In Hematopoietic CellsMolecular Therapy, 2006
- Therapeutic gene causing lymphomaNature, 2006
- Mutagenesis and Oncogenesis by Chromosomal Insertion of Gene Transfer VectorsHuman Gene Therapy, 2006
- Report from the 2nd Stem Cell Clonality and Genotoxicity RetreatMolecular Therapy, 2005
- Leukemias following retroviral transfer of multidrug resistance 1 (MDR1) are driven by combinatorial insertional mutagenesisBlood, 2005
- In VivoSelection of Human Hematopoietic Cells in a Xenograft Model Using Combined Pharmacologic and Genetic ManipulationsHuman Gene Therapy, 2003
- LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1Science, 2003
- Detection of Ecotropic Replication-Competent Retroviruses: Comparison of S+/L-and Marker Rescue AssaysHuman Gene Therapy, 2002
- Hematoprotection and enrichment of transduced cells in vivo after gene transfer of MGMTP140K into hematopoietic stem cellsCancer Gene Therapy, 2002
- Murine Leukemia Induced by Retroviral Gene MarkingScience, 2002